What does it mean when we say we need to focus on the total or whole patient?
Read More »Production Assistant, Diabetes In Control
The Most Common Hassle For Type 1 Diabetes Patients
Barrier means more work including monitoring more often and making more adjustments.
Read More »The Future of Cardiovascular Research
Trial shows mobile devices may be useful in future health studies.
Read More »SGLT-2 or No?
Now that we have a drug (SGLT-2) that can prevent the death of those with diabetes by 38%, do you see yourself informing your patients about this option or will you stay with the status quo? 1) inform patients 2) Stay the course Follow the link to share your opinion!
Read More »Question 868
According to the Standards of Medical Care in Diabetes, which medication class places asymptomatic patients at increased risk of developing type 2 diabetes and is an additional indication for diabetes screening? A. Atypical antipsychotics B. Glucocorticoids C. Both A and B D. Neither A nor B Did you get it right? Follow the link to find out!
Read More »A New Paradigm in the Understanding and Treatment of the Metabolic Syndrome, Part 2
As concluded in the previous newsletter in this series, “Evolutionary selection for insulin resistance in a cyclic environment: brain clocks and control of peripheral metabolism” the brain is equipped with circadian neurophysiological mechanisms to induce (and reverse) the insulin resistant state that evolved as a survival strategy against ensuing environmental stresses such as prolonged (seasonal) lack of food availability. A central facilitator of this insulin resistance induction is a diminution of the circadian peak in dopaminergic activity at the SCN. Neurotoxin induced destruction of these dopaminergic projections to the clock of insulin sensitive animals induces marked insulin resistance and glucose intolerance without alterations in food consumption.
Read More »How to Best Add or Adjust Medications
Man, 51 years of age, type 1 diabetes for 32 years. Patient also has history of Class II obesity, CVA, MI and insulin resistance. Patient referred to Obesity Center for weight loss. A1c was 8.2%. Plan was to start Symlin. Symlin was added at 30mcg daily before dinner. I recommended he get a CGM. He did.
Read More »EMPA-REG Outcome Trial, Part 4
In this week's Homerun Slides, the vital stats of patients on the placebo and empagliflozin 10- and 25-gram study.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #57: Mechanisms of Insulin Signal Transduction Part 1 of 8
Fuel homeostasis: The peptide hormone insulin is secreted from pancreatic beta cells, and exerts a broad spectrum of anabolic effects in multiple tissues. In response to a meal, insulin stimulates uptake and storage of carbohydrate, fat, and amino acids, while, at the same time, antagonizing the catabolism of these fuel reserves.
Read More »Preventing CV Death in Patients With Diabetes
What do we need to tell our patients about preventing the risk for death?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.